期刊文献+

两株灭活轮状病毒疫苗的免疫效果 被引量:1

Immune effects of inactivated rotavirus vaccines prepared with two strains
原文传递
导出
摘要 目的研究轮状病毒(Rotavirus,RV)P[8]G1和P[2]G3株灭活疫苗的免疫原性及不同血清型间的交叉识别作用。方法采用Vero细胞转瓶培养RV,经纯化灭活、佐剂吸附等工艺,制备RV P[8]G1和P[2]G3株灭活疫苗,分别经肌内免疫Wistar大鼠和猕猴,采用ELISA法和微量病毒中和试验检测大鼠和猕猴血清中RV特异性抗体效价和中和抗体效价,流式细胞术检测猕猴血液中CD4+和CD8+T细胞的数量。结果 P[8]G1和P[2]G3株疫苗样品的RV抗原含量分别为10 240和5 120 EU/ml;免疫2次后,P[8]G1和P[2]G3株疫苗诱导大鼠产生的血清IgG抗体GMT分别为(43 407.71±1 654.51)和(41 520.61±2 047.61),诱导猕猴产生的血清IgG抗体GMT分别为(13 654.45±3 125.27)和(10 350.68±997.83);单一血清型疫苗免疫后产生的中和抗体具有型间交叉识别作用;2株疫苗免疫猕猴后均能刺激其CD4+T淋巴细胞增殖,CD8+T淋巴细胞无明显变化。结论 2株RV灭活疫苗均具有良好的免疫原性及型间交叉识别作用。 Objective To investigate the immunogenicity and cross protective effects of inactivated rotavirus(RV) vaccines prepared with P[8]G1 and P[2]G3 strains.Methods RV P[8]G1 and P[2]G3 strains were cultured in Vero cells in rolling bottle,then purified,inactivated and adsorbed with adjuvant to prepare inactivated vaccine respectively.Wistar rats and rhesus macaques were immunized with the prepared vaccines separately,of which the RV specific antibody and neutralizing antibody titers in sera were determined by ELISA and microneutralization assay respectively.The CD4+ and CD8+ T lymphocytes in blood of rhesus macaques were counted by flow cytometry.Results The RV antigen contents in vaccines prepared with P[8]G1 and P[2]G3 strains were 10 240 and 5120 EU / ml respectively.The serum GMTs of IgG induced by two doses of vaccines prepared with P[8]G1 and P[2]G3 strains were(43 407.71 ± 1 654.51) and(41 520.61 ± 2 047.61) in rats while(13 654.45 ± 3 125.27) and(10 350.68 ± 997.83) in rhesus macaques,respectively.The neutralizing antibody induced by vaccine of a single serotype showed cross protective effect against various serotypes.Both the vaccines prepared with two strains stimulated the proliferation of CD4+ T lymphocytes in rhesus macaques,while showed no significant effect on proliferation of CD8+ T lymphocytes.Conclusion Both the vaccines prepared with P[8]G1 and P[2]G3 strains showed good immunogenicity and cross protective effect against various serotypes of RV.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第3期262-265,共4页 Chinese Journal of Biologicals
基金 云南省社会发展科技计划国际合作项目(2008CA028) 云南省应用基础研究计划面上项目(2009CD142)
关键词 轮状病毒疫苗 灭活疫苗 免疫反应 Rotavirus vaccine Inactivated vaccine Immune response
  • 相关文献

参考文献15

二级参考文献16

共引文献16

同被引文献22

  • 1Eisenberg DF, Gu T, Krishnarajah G. Adherence to rotavirus vaccination quality measures in a commercially insured popu- lation [J]. Hum Vaccin Immunother, 2013, 9 (2): 389-397.
  • 2Iw ata S, Nakata S, Ukae S, et al. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double- blind, placebo-controlled, muhicenter trial [J]. Hum Vaccin Immunother, 2013, 9 (8): 1626-1633.
  • 3World Health Organization. Rotavirus vaccines. WHO position paper-January 2013 [ J 1. Wkly Epidemiol Rec, 2013, 88 (5): 49-64.
  • 4Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants [J]. N Engl J Med, 2010, 362 (4): 289-298.
  • 5Wang YH, Azevedo M, Saif LJ, et al. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets [J]. Vaccine, 2010, 28(33): 5432-5436.
  • 6Moon S, Wang YH, Edens C, et al. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch [J]. Vaccine, 2013, 31(34): 3396-3402.
  • 7Jiang BM, Wang YH, Glass RI. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity ? Evidence from animal studies [J]. Hum Vaccin Immunother, 2013, 9 (8): 1-4.
  • 8Jiang BM, Gentsch JR, Glass RI. Inactivated rotavirus vaccines: a priority for accelerated vaccine development [J]. Vaccine, 2008, 26 (52): 6754-6758.
  • 9Zhang B, Yi S, Ma Y, et al. Immunogenicity of a scalable inactivated rotavirus vaccine in mice [J]. Hum Vaccin, 2011, 7 (2): 248-257.
  • 10Madhi SA, Kirsten M, Louw C, et ol. Efficacy and immu- nogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial [J]. Vaccine, 2012, 30 (Suppl 1 ): A44-A51.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部